|
MedChemExpress
injection Injection, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cu+cpt+4a/CU-CPT+4a/pmc12868900-373-12-19 Average 95 stars, based on 1 article reviews
injection - by Bioz Stars,
2026-09
95/100 stars
|
Buy from Supplier |
|
CU-CPT 4a (Cat No.: I011048) is a selective inhibitor of toll-like receptor 3 (TLR3) signaling, which plays a key role in innate immune activation and antiviral responses. By blocking TLR3-mediated recognition of double-stranded RNA, CU-CPT
|
Buy from Supplier |
|
Tocris
cu cpt 4a ![]() Cu Cpt 4a, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cu+cpt+4a/CU+CPT+4a/pmc09287177-310-30-35 Average 94 stars, based on 1 article reviews
cu cpt 4a - by Bioz Stars,
2026-09
94/100 stars
|
Buy from Supplier |
|
Tocris
tlr3 ![]() Tlr3, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cu+cpt+4a/CU+CPT+4a/pm29378643-193-27-31 Average 92 stars, based on 1 article reviews
tlr3 - by Bioz Stars,
2026-09
92/100 stars
|
Buy from Supplier |
|
ApexBio
tlr3 inhibitor cu cpt 4a ![]() Tlr3 Inhibitor Cu Cpt 4a, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cu+cpt+4a/tlr3+inhibitor+cu+cpt+4a/pm31885603-94-1-6 Average 90 stars, based on 1 article reviews
tlr3 inhibitor cu cpt 4a - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Selective TLR3 inhibitor(IC50 = 3.44 μM in RAW 264.7 cells)
|
Buy from Supplier |
|
Product descriptionCU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .
|
Buy from Supplier |
Image Search Results
Journal: Oncogene
Article Title: HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps
doi: 10.1038/s41388-022-02248-3
Figure Lengend Snippet: A Effect of 67NR and 4T1 exosomes treatment on HAO1 expression in alveolar epithelial cells by Western blot analysis. B Effect of transfection of RNA isolated from 67NR and 4T1 exosomes on HAO1 expression in alveolar epithelial cells by Western blot analysis. C Effect of poly (I:C) treatment on HAO1 expression in alveolar epithelial cells by Western blot analysis. D Effect of poly (I:C) inhalation on HAO1 expression in mice lung by Western blot analysis. E Detection of oxalate production in alveolar epithelial cells treated with poly(I:C) or poly(I:C) + CCPST. Means ± s.e.m are provided ( n = 3). F Detection of TLR3 expression in alveolar epithelial cells infected with sg-control or sg-Tlr3 lentivirus. G Detection of HAO1 expression in alveolar epithelial cells treated with 4T1 exosomes, 4T1 exosomes + CU CPT 4a or 4T1 exosomes + sg-Tlr3 lentivirus by Western blot analysis. H Detection of oxalate production in alveolar epithelial cells treated with 4T1 exosomes, 4T1 exosomes + CU CPT 4a or 4T1 exosomes + sg-Tlr3 lentivirus. I Effect of IRF3 over-expression on IRF3, P-IRF3 and HAO1 expression in alveolar epithelial cells by Western blot analysis. J Diagram of the HAO1 promoter showing the location of IRF3 binding sites. K Luciferase activity of HAO1-promoter construct after transfection of IRF3 plasmid in alveolar epithelial cells. L Detection of IRF3, P-IRF3 and HAO1 expression in alveolar epithelial cells treated with 4T1 exosomes or 4T1 exosomes + shIRF3 by Western blot analysis. M Detection of oxalate production in alveolar epithelial cells treated with 4T1 exosomes or 4T1 exosomes + shIRF3. Means ± s.e.m are provided ( n = 3). N Schematic diagram of the role of HAO1-mediated oxalate metabolism at pre-metastatic stage and metastatic stage. *** P < 0.001, **** P < 0.0001 according to two-tailed Student’s t test.
Article Snippet: The potassium oxalate (20 μM, Aladdin), DNase I (100 U/ml, Aladdin), CCPST (200 μM, Key organics), PMA (10 nM, MedChemExpress), apocynin (10 μM, MedChemExpress), SB 203580 (500 nM, MedChemExpress) and
Techniques: Expressing, Western Blot, Transfection, Isolation, Infection, Control, Over Expression, Binding Assay, Luciferase, Activity Assay, Construct, Plasmid Preparation, Two Tailed Test
Journal: Genome biology
Article Title: A Reproducibility-Based Computational Framework Identifies an Inducible, Enhanced Antiviral State in Dendritic Cells from HIV-1 Elite Controllers.
doi: 10.1186/s13059-017-1385-x
Figure Lengend Snippet: Fig. 4 Immunomodulators can alter the fractional abundance of the c1 mDC phenotype. a Top: Schematic of bulk expression data (Bi) from publicly available perturbation data. Bottom: Each cell’s expression profile (C1j) is correlated with all Bi so as to compare similarities of the single-cell cluster 1 to all bulk expression profiles. b Volcano plot of negative log meta-analysis false discovery rate (FDR) vs mean difference in “TLR stimulation score” between c1 and c3–5. Scores are computed from weighted correlations between single-cell profiles and transcriptional patterns from human DCs (see “Methods”) after 48 h of stimulation with media control (black) or agonists for either TLR2 (PAM3CSK4, dark blue), TLR3 (Poly I:C, green), TLR4 (LPS, orange), TLR7/8 (Gard, purple), or TLR9 (CpG, light blue). Tests reproduced with FDR < 0.01 in both stratified analyses are highlighted in blue. c Proportion of CD64Hi,PDL1Hi cells among mDCs from PBMCs isolated from HIV-negative individuals cultured in the absence or the presence of VSV-G pseudotyped HIV-1, alone or in combination with TLR ligands (TLRL: TLR2L, PGNA, n = 11; TLR3L, Poly I:C, n = 11; TLR4L, LPS, n = 8; TLR8L, CL097, n = 11; Methods). Statistical significance was calculated using Kruskal–Wallis and Dunn’s tests (**, p < 0.01). d Proportions of CD64Hi, PD-L1Hi cells among mDCs from healthy individuals (indigo) and elite controllers (olive) cultured in the absence or the presence of Poly I:C and polymer nanoparticles loaded with single-stranded (ss) or double stranded (ds) 100 nucleotide HIV-1 DNA (see “Methods”; n = 8, HIV negative individuals; n = 7, ECs). Statistical significance was calculated using either two-tailed Wilcoxon signed-rank test (black) or two-tailed Mann–Whiney test (red) to compare differences within or among patient groups, respectively (**, p < 0.01; *, p < 0.05). e Proportion of proliferating CD4+ or CD8+ T cells after culture with Hi or Lo mDC from a HD stimulated with TLRL3 and nanoparticles containing gag single-stranded DNA (*, p < 0.05; two-tailed Wilcoxon signed-rank test. n = 6). f Volcano plot of negative log IDR vs mean difference in upstream regulatory score between c1 and c3–5 based on single-cell correlations with short hairpin RNA- perturbation profiles from mouse DCs stimulated with LPS for 6 h (adapted from Chevrier et al. [32]; see “Methods”). The net effect (activate, inhibit, both) of each perturbation is denoted by color (red, blue, gray, respectively), as is its breadth (size). g Proportions of CD64Hi,PD-L1Hi cells among EC mDCs cultured in the presence or absence of virus and DMSO (control, magenta) or BX795 TBK1 inhibitor (cyan; n = 10; see “Methods”). Statistical significance was calculated using a two-tailed Wilcoxon signed-rank test (*, p < 0.05)
Article Snippet: In the TLR antagonist studies, mDCs from PBMCs were treated with VSV-G pseudotyped HIV-1 (see “In vitro infection with HIV-1 virus”) alone or in combination with a
Techniques: Expressing, Control, Isolation, Cell Culture, Polymer, Two Tailed Test, shRNA, Virus